Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

[Epigenetics in transgenerational responses to environmental impacts: from facts and gaps].

Junien C, Panchenko P, Fneich S, Pirola L, Chriett S, Amarger V, Kaeffer B, Parnet P, Torrisani J, Bolaños Jimenez F, Jammes H, Gabory A.

Med Sci (Paris). 2016 Jan;32(1):35-44. doi: 10.1051/medsci/20163201007. Epub 2016 Feb 5. Review. French.

2.

[The new paradigm of the developmental origin of health and diseases (DOHaD)--Epigenetics and environment: evidence and missing links].

Junien C, Panchenko P, Pirola L, Amarger V, Kaeffer B, Parnet P, Torrisani J, Bolaños Jimenez F, Jammes H, Gabory A.

Med Sci (Paris). 2016 Jan;32(1):27-34. doi: 10.1051/medsci/20163201006. Epub 2016 Feb 5. Review. French.

3.

Salivary MicroRNA in Pancreatic Cancer Patients.

Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L, Torrisani J, Cordelier P.

PLoS One. 2015 Jun 29;10(6):e0130996. doi: 10.1371/journal.pone.0130996. eCollection 2015.

4.

[Advance in the biology of pancreatic of cancer].

Buscail L, Bournet B, Dufresne M, Torrisani J, Cordelier P.

Bull Cancer. 2015 Jun;102(6 Suppl 1):S53-61. doi: 10.1016/S0007-4551(15)31218-2. Review. French.

PMID:
26118878
5.

Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.

Tréhoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, Jonckheere N, Van Seuningen I.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2392-403. doi: 10.1016/j.bbamcr.2015.05.033. Epub 2015 May 31.

6.

Adverse childhood experiences and physiological wear-and-tear in midlife: Findings from the 1958 British birth cohort.

Barboza Solís C, Kelly-Irving M, Fantin R, Darnaudéry M, Torrisani J, Lang T, Delpierre C.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E738-46. doi: 10.1073/pnas.1417325112. Epub 2015 Feb 2.

7.

First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

Buscail L, Bournet B, Vernejoul F, Cambois G, Lulka H, Hanoun N, Dufresne M, Meulle A, Vignolle-Vidoni A, Ligat L, Saint-Laurent N, Pont F, Dejean S, Gayral M, Martins F, Torrisani J, Barbey O, Gross F, Guimbaud R, Otal P, Lopez F, Tiraby G, Cordelier P.

Mol Ther. 2015 Apr;23(4):779-89. doi: 10.1038/mt.2015.1. Epub 2015 Jan 14.

8.

The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.

Hanoun N, Fritsch S, Gayet O, Gigoux V, Cordelier P, Dusetti N, Torrisani J, Dufresne M.

J Biol Chem. 2014 Dec 19;289(51):35593-604. doi: 10.1074/jbc.M114.620104. Epub 2014 Oct 29.

9.

MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.

Gayral M, Jo S, Hanoun N, Vignolle-Vidoni A, Lulka H, Delpu Y, Meulle A, Dufresne M, Humeau M, Chalret du Rieu M, Bournet B, Sèlves J, Guimbaud R, Carrère N, Buscail L, Torrisani J, Cordelier P.

World J Gastroenterol. 2014 Aug 28;20(32):11199-209. doi: 10.3748/wjg.v20.i32.11199. Review.

10.

Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.

Bournet B, Gayral M, Torrisani J, Selves J, Cordelier P, Buscail L.

World J Gastroenterol. 2014 Aug 21;20(31):10758-68. doi: 10.3748/wjg.v20.i31.10758. Review.

11.

The Role of the 3' Untranslated Region in the Post-Transcriptional Regulation of KLF6 Gene Expression in Hepatocellular Carcinoma.

Diab T, Hanoun N, Bureau C, Christol C, Buscail L, Cordelier P, Torrisani J.

Cancers (Basel). 2013 Dec 19;6(1):28-41. doi: 10.3390/cancers6010028.

12.

[Kras oncogene and pancreatic cancer: thirty years after].

Bournet B, Dufresne M, Selves J, Torrisani J, Cordelier P, Buscail L.

Med Sci (Paris). 2013 Nov;29(11):991-7. doi: 10.1051/medsci/20132911015. Epub 2013 Nov 20. Review. French.

13.

DNA methylation and cancer diagnosis.

Delpu Y, Cordelier P, Cho WC, Torrisani J.

Int J Mol Sci. 2013 Jul 18;14(7):15029-58. doi: 10.3390/ijms140715029. Review.

14.

miRNA in clinical practice: pancreatic cancer.

Humeau M, Torrisani J, Cordelier P.

Clin Biochem. 2013 Jul;46(10-11):933-6. doi: 10.1016/j.clinbiochem.2013.03.019. Epub 2013 Apr 6. Review.

PMID:
23570860
15.

The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool.

Delpu Y, Lulka H, Sicard F, Saint-Laurent N, Lopez F, Hanoun N, Buscail L, Cordelier P, Torrisani J.

PLoS One. 2013;8(1):e55513. doi: 10.1371/journal.pone.0055513. Epub 2013 Jan 31.

16.

An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function.

Kar S, Deb M, Sengupta D, Shilpi A, Parbin S, Torrisani J, Pradhan S, Patra S.

Epigenetics. 2012 Sep;7(9):994-1007. Epub 2012 Aug 16. Review.

17.

Genetic and epigenetic alterations in pancreatic carcinogenesis.

Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P.

Curr Genomics. 2011 Mar;12(1):15-24. doi: 10.2174/138920211794520132.

18.

Molecular endoscopic ultrasound for diagnosis of pancreatic cancer.

Bournet B, Pointreau A, Delpu Y, Selves J, Torrisani J, Buscail L, Cordelier P.

Cancers (Basel). 2011 Feb 24;3(1):872-82. doi: 10.3390/cancers3010872.

19.

The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.

Hanoun N, Bureau C, Diab T, Gayet O, Dusetti N, Selves J, Vinel JP, Buscail L, Cordelier P, Torrisani J.

J Hepatol. 2010 Nov;53(5):880-8. doi: 10.1016/j.jhep.2010.04.038. Epub 2010 Jul 23.

PMID:
20801538
20.

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J.

Clin Chem. 2010 Jul;56(7):1107-18. doi: 10.1373/clinchem.2010.144709. Epub 2010 Apr 29.

Supplemental Content

Loading ...
Support Center